965.40
-0.57%
ICICI Securities Limited
Vijaya Diagnostic Centre’s (Vijaya) Q2FY24 result was a beat vs our estimates driven by 18.3% YoY growth in non-covid business. Test volume growth remained healthy at 18.7% YoY. In Q2, it commercialised a new hub in Kolkata; the company is witnessing good traction and expects the hub to breakeven in next three quarters.
Number of FII/FPI investors increased from 155 to 181 in Mar 2025 qtr.
More from Vijaya Diagnostic Centre Ltd.
Recommended